mRNA Hair Loss Therapies
A new contender in the dermatology field is GeneSkin, an mRNA-based platform developed at Harvard’s Wyss Institute, which aims to address some of the unmet needs in skin and hair health. The minds behind GeneSkin include geneticist George Church and his team, who have been studying which genes help skin and hair stay healthy. By…
A subsidiary of a European pharmaceutical company has launched in the US to trial a new drug against pattern hair loss. Also, preclinical data from the stock market-traded company Omega Therapeutics is shown. Dermaliq DLQ01 Drug Candidate On January 18, 2022, Novaliq GmbH and strategic investment partners announced the formation of a Dermaliq Therapeutics Inc.,…